APCER Pharma’s revenues grew by a lot more than 40 percent in 2013 APCER Pharma, the global service provider of strategic and outsourced providers for clinical basic safety truly, pharmacovigilance, medical affairs, and regulatory operations, announced today that revenues grew by a lot more than 40 percent in 2013 when compared to previous year. The held company privately, which ended its fiscal calendar year on March 31, gained eight new clients during the period and now serves 5 of the Top 20 global pharmaceutical businesses. Our strong development was driven by an excellent balance of existing customers expanding our part and new businesses requiring our global knowledge, said Suneet Walia, Chief and President Executive Officer of APCER Pharma Solutions, Inc pilule viagra pour femme ., the group's US division.
According to the groups, science supports a stronger standard. ‘Scientific and epidemiological studies have shown that breathing ozone could cause adverse health effects at concentrations lower than the 75 parts per billion 8-hour average standard,’ the groups wrote. Exposure can result in respiratory and cardiovascular wellness effects, increase mortality and adversely affect sensitive groups, including those with asthma, seniors and outdoor workers. Children are particularly vulnerable. The combined organizations said, ‘Given the pounds of evidence, we desire you to create the eight-hour ozone regular at 60 parts per billion to protect against known and anticipated adverse health effects and to give a margin of basic safety as needed by the Clean Air Act.’..